Authors

• Arash Rezazadeh Kalebasty
• Minh‐Ha Tran (ORCID: https://orcid.org/0000-0002-9974-5277)
• Sheetal Desai (ORCID: https://orcid.org/0000-0002-7180-8387)
• Matthew Nguyen
• Mina Ibrahim Tadros (ORCID: https://orcid.org/0000-0001-7092-8603)
• Vu Q. Nguyen (ORCID: https://orcid.org/0000-0001-7802-8028)
• Umut Selamet (ORCID: https://orcid.org/0000-0002-9347-2933)
• Ramy Magdy Hanna (ORCID: https://orcid.org/0000-0003-1807-8909)
• Samir Patel (ORCID: https://orcid.org/0000-0002-4471-2996)
• Stefan O. Ciurea (ORCID: https://orcid.org/0000-0001-8597-3271)
• Caroline Gee

Institutions

• University of California, Irvine (US)
• Los Angeles Medical Center (US)
• Dana-Farber Cancer Institute (US)
• Dana-Farber/Harvard Cancer Center (US)

Publication Details

Journal

BMC Nephrology

Published

2025-10-24

DOI

https://doi.org/10.1186/s12882-025-04487-4

Primary Topic

Complement system in diseases

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Bristol-Myers Squibb
• AstraZeneca
• Sanofi
• Exelixis
• Eisai
• Genentech